CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-04 | Schafer Klaus Director | Grant or award · Stock Option (option to buy) | +1,791 | 1,791 | ||
| 2017-05-04 | Hodges Philip Director | Grant or award | +1,278,471 | 1,278,471 | ||
| 2017-05-04 | Hodges Philip Director | Grant or award | +36,785 | 36,785 | ||
| 2017-05-04 | Hodges Philip Director | Grant or award | +4,455 | 4,455 | ||
| 2017-05-04 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Option (option to buy) | +55,120 | 55,120 | ||
| 2017-05-04 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Option (option to buy) | +8,956 | 8,956 | ||
| 2017-05-04 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Option (option to buy) | +8,956 | 8,956 | ||
| 2017-05-04 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Option (option to buy) | +11,235 | 11,235 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award | +17,787 | 17,787 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award · Stock Options (option to buy) | +125,887 | 125,887 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award · Stock Options (option to buy) | +71,644 | 71,644 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award · Stock Options (option to buy) | +91,733 | 91,733 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award · Stock Options (option to buy) | +183,347 | 183,347 | ||
| 2017-05-04 | Enright William See Remarks | Grant or award · Stock Options (option to buy) | +99,927 | 99,927 | ||
| 2017-05-04 | CZEREPAK ELIZABETH See Remarks | Grant or award · Stock Option (option to buy) | +178,595 | 178,595 | ||
| 2017-05-04 | CZEREPAK ELIZABETH See Remarks | Grant or award · Stock Option (option to buy) | +18,727 | 18,727 | ||
| 2017-05-04 | Drutz David Director | Grant or award | +20,777 | 20,777 | ||
| 2017-05-04 | Drutz David Director | Grant or award · Stock Option (option to buy) | +4,755 | 4,755 | ||
| 2017-05-04 | Drutz David Director | Grant or award · Stock Option (option to buy) | +1,791 | 1,791 | ||
| 2017-05-04 | Drutz David Director | Grant or award · Stock Option (option to buy) | +1,791 | 1,791 |
Page 32 of 43 · 845 trades